Th17-cytokine blockers as a new approach for treating inflammatory bowel disease

Author： Monteleone Ivan   Pallone Francesco   Monteleone Giovanni  

Publisher： Informa Healthcare

ISSN： 0785-3890

Source： Annals of Medicine, Vol.43, Iss.3, 2011-05, pp. : 172-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms

By Joanna Balding   Wendy J. Livingstone   Judith Conroy   Lesley Mynett-johnson   Donald G. Weir   Nasir Mahmud   Owen P. Smith  

Mediators of Inflammation, Vol. 13, Iss. 3, 2004-06 ,pp. : 181-187

Informa Healthcare

Access to resources Recommend Favorite

Pro‐ and anti‐inflammatory cytokine gene single‐nucleotide polymorphisms in inflammatory bowel disease

By  

INTERNATIONAL JOURNAL OF IMMUNOGENETICS, Vol. 42, Iss. 1, 2015-02 ,pp. : 38-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proposed new approach for treating Paget's disease of bone

By Mahmood W.  

Irish Journal of Medical Science, Vol. 180, Iss. 1, 2011-03 ,pp. : 121-124

Springer Publishing Company

Access to resources Recommend Favorite

Cytokines in inflammatory bowel disease

By Beck P. L.   Wallace J. L.  

Mediators of Inflammation, Vol. 6, Iss. 2, 1997-04 ,pp. : 95-103

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory bowel disease in Asia

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 3, 2010-03 ,pp. : 436-438

John Wiley & Sons Inc

Access to resources Recommend Favorite